There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Voltage-gated Na(+) channels are heteromeric membrane glycoproteins responsible for
the generation of action potentials. A number of diverse lipid-soluble neurotoxins,
such as batrachotoxin, veratridine, aconitine, grayanotoxins, pyrethroid insecticides,
brevetoxins and ciguatoxin, target voltage-gated Na(+) channels for their primary
actions. These toxins promote Na(+) channel opening, induce depolarization of the
resting membrane potential, and thus drastically affect the excitability of nerve,
muscle and cardiac tissues. Poisoning by these lipid-soluble neurotoxins causes hyperexcitability
of excitable tissues, followed by convulsions, paralysis and death in animals. How
these lipid-soluble neurotoxins alter Na(+) channel gating mechanistically remains
unknown. Recent mapping of receptor sites within the Na(+) channel protein for these
neurotoxins using site-directed mutagenesis has provided important clues on this subject.
Paradoxically, the receptor site for batrachotoxin and veratridine on the voltage-gated
Na(+) channel alpha-subunit appears to be adjacent to or overlap with that for therapeutic
drugs such as local anaesthetics (LAs), antidepressants and anticonvulsants. This
article reviews the physiological actions of lipid-soluble neurotoxins on voltage-gated
Na(+) channels, their receptor sites on the S6 segments of the Na(+) channel alpha-subunit
and a possible linkage between their receptors and the gating function of Na(+) channels.